Learn How TB Test Results Are Processed

Understanding TB Testing Basics and Why Results Matter

Tuberculosis (TB) testing is a medical process used to determine whether a person has been exposed to or infected with the bacteria that causes tuberculosis. The information in this guide explains how healthcare providers process and interpret TB test results, what different outcomes mean, and what typically happens after testing.

Tuberculosis remains a global health concern. According to the World Health Organization, approximately 10 million people developed TB disease in 2022. In the United States, the Centers for Disease Control and Prevention (CDC) reported about 7,500 TB cases in 2022. While these numbers have decreased over decades due to improved testing and treatment, TB testing continues to be an important part of public health screening and clinical diagnosis.

There are two main types of TB tests that healthcare providers use: skin tests and blood tests. Skin tests have been used for over a century, while blood tests represent newer technology. Both methods look for evidence that a person's immune system has encountered TB bacteria. However, they work differently and require different processing methods.

Understanding how results are processed helps people know what to expect during the testing process and what information their healthcare provider will receive. Test processing involves several steps: sample collection, laboratory procedures, interpretation by trained personnel, and communication of results back to the patient and their doctor.

Practical Takeaway: TB testing identifies whether someone has TB infection or disease. Learning how results are processed helps you understand what happens to your test sample and how long it typically takes to receive information about your results.

The Tuberculin Skin Test (TST) Process and Result Interpretation

The tuberculin skin test, also called the Mantoux test or intradermal tuberculin test, is one of the most commonly used TB screening methods worldwide. In this test, a healthcare provider injects a small amount of purified protein derivative (PPD) into the skin of the forearm. The injection itself takes only seconds, but the actual test results don't appear until 48 to 72 hours later.

During the processing period after injection, the immune system responds if it has previously encountered TB bacteria. This response causes the skin at the injection site to become hard and swollen (induration). The hardening of the skin—not redness—is what matters for interpretation. A healthcare worker measures this induration in millimeters, typically 48 to 72 hours after injection, though some guidelines allow reading up to seven days after injection.

The interpretation of TST results depends on several factors beyond just the size of the induration. Healthcare providers consider the patient's risk factors, medical history, symptoms, and other test information. The CDC provides specific measurement thresholds:

• An induration of 5 millimeters or more is considered positive in people with HIV infection, close contacts of TB patients, people with abnormal chest X-rays, and those with other immunocompromised conditions
• An induration of 10 millimeters or more is considered positive in people with recent immigration from TB-endemic areas, healthcare workers, people with certain medical conditions, and other groups with increased TB risk
• An induration of 15 millimeters or more is considered positive in people without known TB risk factors

One important aspect of TST processing is accounting for false positives and false negatives. False positives can occur in people vaccinated with the BCG vaccine, which is used in many countries outside the United States. False negatives can occur in people with severe immunosuppression, recent TB infection (before the immune response develops), and certain other medical conditions. Healthcare providers know about these limitations and use them to guide interpretation.

Practical Takeaway: TST results require both a measurement at 48-72 hours and clinical judgment from a healthcare provider. The same skin induration size may mean different things depending on your health history and risk factors.

Blood-Based TB Tests and Laboratory Processing

Interferon-gamma release assays (IGRAs) are blood tests that detect TB infection by measuring the immune response to TB antigens. Common IGRAs include the QuantiFERON-Gold In-Tube test and the T-SPOT.TB test. These tests represent more modern technology than the skin test and have different processing requirements.

The blood sample collection process is straightforward—a healthcare worker draws blood into special collection tubes containing TB antigens. The actual test requires incubating the blood sample at body temperature (37 degrees Celsius) for 16 to 24 hours. During this incubation period, the patient's white blood cells that have encountered TB bacteria respond by releasing interferon-gamma, a chemical messenger. This chemical accumulates in the test tube and is then measured using laboratory equipment.

After the incubation period, laboratory technicians process the samples using enzyme-linked immunosorbent assay (ELISA) or similar technology. This process measures the amount of interferon-gamma present in the sample. The laboratory compares the results against established cutoff values to determine whether the result is positive, negative, or indeterminate.

IGRA results typically come back within one to three days, which is faster than the TST process since you don't need to wait 48 to 72 hours before the result can be read. The blood test is less affected by BCG vaccination history, making interpretation more straightforward for people who received the BCG vaccine. However, IGRA tests can still show false negatives in people with severe immune system problems.

Some advantages of IGRA processing include requiring only one visit to collect the blood sample (compared to TST's two visits—one for injection and one for reading), less operator-dependent interpretation, and faster turnaround times in many laboratory settings. However, IGRA tests cost more than TST and require specialized laboratory equipment, which may limit availability in some areas.

Practical Takeaway: Blood-based TB tests require incubation and laboratory measurement rather than visual inspection. These tests provide results within a few days and are unaffected by prior BCG vaccination.

What Happens After Testing: Next Steps and Follow-Up Procedures

After a TB test result is processed and reported, the next steps depend on whether the result is positive, negative, or indeterminate. Understanding what typically occurs after testing helps people know what to expect and what further evaluation might be recommended.

If a TB test result is negative, this usually means the person does not have TB infection or disease. However, a negative result does not completely rule out TB in certain situations. For example, if someone was recently exposed to TB and tested too soon—before their immune system developed a response—a negative result might not accurately reflect their status. In these cases, a healthcare provider might recommend retesting at a later date, typically two to eight weeks after exposure.

If a TB test result is positive, this indicates TB infection. However, a positive test does not automatically mean someone has TB disease. A positive test means the person's immune system has encountered TB bacteria at some point. Further evaluation is necessary to determine whether someone has latent TB infection (where the bacteria is in the body but not causing disease) or active TB disease (where the bacteria is multiplying and causing illness).

When further evaluation is needed, healthcare providers typically order a chest X-ray to look for signs of TB disease in the lungs. They may also collect sputum samples (coughed-up material) to look for TB bacteria under a microscope or to perform TB culture and drug susceptibility testing. Sputum samples are sent to a laboratory where technicians can identify TB bacteria and determine what medications would be effective.

The processing of sputum samples involves several steps. First, the sample is treated with a chemical solution to separate TB bacteria from other material. The treated sample is then examined under a microscope using special staining techniques that make TB bacteria visible. Additionally, the sample may be cultured (grown in special media) to confirm the diagnosis and test which medications will work against the bacteria. Culture processing takes two to six weeks, though newer rapid molecular tests can provide results within two hours.

For people with positive TB test results and a normal chest X-ray, TB infection is typically treated with preventive medications to reduce the risk of progressing to TB disease. Preventive treatment usually involves taking medications for several months. The exact regimen depends on factors including age, other medical conditions, and potential drug interactions.

Practical Takeaway: A positive TB test is not the end of the evaluation process. Healthcare providers typically order additional tests